Ploughshare Innovations Ltd.
Unit 2, Nine Mile Water Business Park, Nether Wallop, Stockbridge, Hampshire SO20 8DR United Kingdom
T: +44 (0) 1794 301602
© Ploughshare Innovations Ltd 2013
Dstl’s research is held in the highest regard with a worldwide reputation.
Biomedical, Clinical & Pharmaceutical
Biomedical, Clinical & Pharmaceutical – Fitting Technology for Industry
Within this broad scientific area, our technology falls into the following categories:
- Vaccine Development
- Skin-care/Cosmetic
- Diagnostic Tools & Infection prevention
- Detection/Decontamination
Brief summaries of our specialist solutions are given below, and you can also download information sheets in pdf format (just enter your email address when prompted to initiate the required document download).
In a sector that requires such extensive timescales for testing and regulation, the level of development undertaken by Dstl offers your organisation clear value. It means that the technology we provide can help you go to market far more quickly and cost effectively, when compared to ‘starting from fresh’.
By licensing our technology you are benefiting from a £350+ Million R&D budget and the capabilities of 2500+ scientists.
Antibody Fragments
Antibody pharmaceutical compositions that can neutralise the effects of toxins, whether derived from microbes, plants, snakes, insects or synthetic poisons, including toxins administered as therapeutics, e.g. botulinum toxin. The composition describes a mixture of an intact antibody, or large antibody fragment, together with a smaller second antibody fragment.
Bacillus Expression System
An improved Bacillus subtilis protein expression system suitable for the production of exogenous proteins of interest.
DNA Trace Recovery
Analysing trace and touch DNA to identify individuals from items found at a crime scene is technically challenging, slow and intensive. This new method dramatically improves the speed and reduces the logistical burden of DNA analysis on handled objects, and allows results to be rapidly generated from touch DNA samples.
Humane Rodenticide
The £200m rodenticide manufacturing market is dominated by products based upon anticoagulants. However, due to issues of concern regarding humaneness, toxicity (resistance) and safety there is increasing pressure upon the industry to develop new products.
Non formaldehyde toxoiding
Scientists at the Defence Science and Technology Laboratory (Dstl) in the UK have developed a method to treat a toxin to produce a toxoid for use in vaccines that does not involve the use of formaldehyde. These toxoids are more stable, quicker to produce and avoid the toxicity associated with formaldehyde.
One Step Antibody Immobilisation for Biosensors
This novel peptide tag allows recombinant proteins to be easily immobilised onto a surface, and also improves their expression and production..
Population Monitoring
A system for monitoring a live population e.g. for outbreaks of disease and data reporting to a remote station for analysis. For more details: .(JavaScript must be enabled to view this email address)
Sample Collection using Lateral Flow Strips
A robust and easy to use device has been developed for swabbing surfaces and the sample run on several different lateral flow test strips. A range of materials from explosives to bacterial contamination can be tested for. The sample is retained in the device for subsequent analysis, or as forensic evidence.
WIBS real time bio-aerosol monitoring
An instrument that can deliver reagent-free, real-time, continuous monitoring of bio-aerosols. This could be used for monitoring of bio-aerosol loads at composting sites, detecting indoor mould spores, environmental research or pharmaceutical clean rooms.